Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-08

Clinical Trial Update: Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula [NA]

View source ↗

Summary

A completed clinical trial indicates improved immunology outcomes in infants fed formula fortified with lactoferrin and human milk oligosaccharides (HMO). The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infant formula fortified with lactoferrin and human milk oligosaccharides (HMO) (Lactoferrin fortified infant formula with HMOs)

Snippet

Sponsor: Heilongjiang Feihe Dairy Co. Ltd. | Conditions: Flu, Cold | NA | Status: COMPLETED